Midatech Pharma (MTP)

Company Profile

Midatech Pharma PLC is a public limited company organized under the laws of England and Wales under registered number 09216368. In this annual report, references to “we,” “us,” “our,” “the Group,” “Company,” “company” or “Midatech” means Midatech Pharma PLC and our consolidated subsidiaries.

Company profile

Ticker

MTP

Exchange

NASDAQ

Website

www.midatechpharma.com/

CEO

Stephen Anthony Stamp

Incorporated

United Kingdom

Location

United Kingdom

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Celgene ...

SEC CIK

0001643918

Corporate docs

Articles of Incorporation & Bylaws

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

MTP stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

424B3

Prospectus supplement

2 Feb 23

6-K

Current report (foreign)

2 Feb 23

424B3

Prospectus supplement

26 Jan 23

6-K

Current report (foreign)

26 Jan 23

424B3

Prospectus supplement

23 Jan 23

6-K

Result of General Meeting

23 Jan 23

6-K

Current report (foreign)

12 Jan 23

424B3

Prospectus supplement

11 Jan 23

6-K

Current report (foreign)

11 Jan 23

424B3

Prospectus supplement

6 Jan 23

Transcripts

MTP

Earnings call transcript

2021 Q2

20 Sep 21

Latest ownership filings

Beneficial ownership report (amended)

Financial summary

Financial statements Chart MTP financial data

Quarter (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 21	Dec 20	Dec 19	Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2022

MTP institutional ownership history Ownership history

6.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	9	7	+28.6%
Opened positions	3	2	+50.0%
Closed positions	1	1	–
Increased positions	1	1	–
Reduced positions	2	1	+100.0%

13F shares	Current	Prev Q	Change
Total value	331.00 k	550.00 k	-39.8%
Total shares	664.24 k	696.19 k	-4.6%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Lombard Odier Asset Management	295.50 k	$131.00 k	0.0%
Renaissance Technologies	201.54 k	$109.00 k	+0.9%
MS Morgan Stanley	82.44 k	$45.00 k	-55.0%
Great Valley Advisor	49.60 k	$27.00 k	NEW
Two Sigma Securities	17.01 k	$9.00 k	NEW
Susquehanna International	14.88 k	$8.00 k	NEW
UBS UBS Group AG - Registered Shares	3.16 k	$2.00 k	-35.7%
Optimum Investment Advisors	100.00	$0.00	0.0%
Group One Trading	10.00	$0.00	0.0%
Proequities	0.00	$0.00

Largest transactions	Shares	Bought/sold	Change
MS Morgan Stanley	82.44 k	-100.89 k	-55.0%
Great Valley Advisor	49.60 k	+49.60 k	NEW
Two Sigma Securities	17.01 k	+17.01 k	NEW
Susquehanna International	14.88 k	+14.88 k	NEW
Advisor	0.00	-12.60 k	EXIT
Renaissance Technologies	201.54 k	+1.80 k	+0.9%
UBS UBS Group AG - Registered Shares	3.16 k	-1.76 k	-35.7%
Proequities	0.00	0.00
Group One Trading	10.00	0.00	0.0%
Optimum Investment Advisors	100.00	0.00	0.0%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.